# Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19

> **NCT04400890** · PHASE2 · TERMINATED · sponsor: **Marvin McCreary, MD** · enrollment: 105 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Resveratrol
- **DIETARY_SUPPLEMENT:** Vitamin D3

## Key facts

- **NCT ID:** NCT04400890
- **Lead sponsor:** Marvin McCreary, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-13
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 105 (ACTUAL)
- **Why stopped:** Feasibility
- **Last updated:** 2023-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04400890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04400890, "Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04400890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*